Concepedia

Ramadevi Gudi

RG

Statistics

Publications

26

Citations

1.4K

H-Index

19

Active since

1988

Affiliations

BioReliance (United States)(Current)

Center for Drug Evaluation and Research

United States Food and Drug Administration

Research Triangle Park Foundation

University of Vermont

Ramadevi Gudi is an author at BioReliance (United States) specializing in toxicology, pharmacology, and pharmacy.

Publications per year

1988–2022

26

Publications

26

Isoenzymes of Pyruvate Dehydrogenase Phosphatase

Boli Huang, Ramadevi Gudi, Pengfei Wu et al. · Journal of Biological Chemistry · 1998 · 214 citations · Full text

, , +14

FDA Approval Summary: Ivosidenib for Relapsed or Refractory Acute Myeloid Leukemia with an Isocitrate Dehydrogenase-1 Mutation

Kelly J. Norsworthy, Lola Luo, Vicky Hsu et al. · Clinical Cancer Research · 2019 · 136 citations

, , +14

FDA Approval Summary: Ruxolitinib for Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease

Donna Przepiorka, Lola Luo, Sriram Subramaniam et al. · The Oncologist · 2019 · 132 citations · Full text

, , +10

Molecular cloning of the p45 subunit of pyruvate dehydrogenase kinase.

Kirill M. Popov, Natalia Y. Kedishvili, Yu Zhao et al. · Journal of Biological Chemistry · 1994 · 84 citations · Full text

, , +5

FDA Approval Summary: Gilteritinib for Relapsed or Refractory Acute Myeloid Leukemia with a <i>FLT3</i> Mutation

Dianne Pulte, Kelly J. Norsworthy, Yaping Wang et al. · Clinical Cancer Research · 2021 · 81 citations · Full text

, , +14

1–5 of 26